ANN ARBOR - GeneVivo creates transgenic – or genetically modified – animals for biomedical research. The transgenics market is $750 million and growing at 12percent - 13 percent per year. GeneVivo’s proprietary method enables the company to expand the market by genetically modifying strains of mice (analogous to breeds of dogs) that were not amenable to transgenesis by previous methods, opening up a much-needed new chest of tools to the research community. Sean Ainsworth, CEO, discusses the company in this Elevator Pitch.
You are currently browsing articles tagged biotechnology.
